UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 176

Sortiert nach

Hematopoietic stem cell mobilization: updated conceptual renditions

Leukemia, 2013-01, Vol.27 (1), p.24-31

2013

Volltextzugriff (PDF)

Mesenchymal stromal cells for osteonecrosis

Journal of translational medicine, 2020-10, Vol.18 (1), p.399-399, Article 399

2020

Volltextzugriff (PDF)

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

Leukemia, 2017-10, Vol.31 (10), p.2161-2171

2017

Volltextzugriff (PDF)

RBC depletion from a PBSC graft

Bone marrow transplantation (Basingstoke), 2017-07, Vol.52 (7), p.1078-1079

2017

Volltextzugriff (PDF)

Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes

Journal of translational medicine, 2020-04, Vol.18 (1), p.177-177, Article 177

2020

Volltextzugriff (PDF)

Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation

Journal of translational medicine, 2022-03, Vol.20 (1), p.121-121, Article 121

2022

Volltextzugriff (PDF)

The osteo-inductive activity of bone-marrow-derived mononuclear cells resides within the CD14+ population and is independent of the CD34+ population

European cells & materials, 2018-03, Vol.35, p.165-177

2018

Volltextzugriff (PDF)

Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5·0, a novel, automatic interface-controlled apheresis system: results from the first feasibility trial

Vox sanguinis, 2011-10, Vol.101 (3), p.237-246

2011

Volltextzugriff (PDF)

The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor

Leukemia, 2013-12, Vol.27 (12), p.2322-2331

2013

Volltextzugriff (PDF)

Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study

Vox sanguinis, 2013-01, Vol.104 (1), p.46-54

2013

Volltextzugriff (PDF)

Effects of the small-molecule inhibitor of integrin α4, TBC3486, on pre-B-ALL cells

Leukemia, 2014-10, Vol.28 (10), p.2101-2104

2014

Volltextzugriff (PDF)

Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation

Bone marrow transplantation (Basingstoke), 2014-11, Vol.49 (11), p.1419-1425

2014

Volltextzugriff (PDF)

Feasibility of IL-15-activated cytokine-induced killer cell infusions after haploidentical stem cell transplantation

Bone marrow transplantation (Basingstoke), 2013-08, Vol.48 (8), p.1141-1143

2013

Volltextzugriff (PDF)

Delayed onset of graft‐versus‐host disease in immunodeficent human leucocyte antigen‐DQ8 transgenic, murine major histocompatibility complex class II‐deficient mice repopulated by human peripheral blood mononuclear cells

Clinical and experimental immunology, 2013-08, Vol.173 (2), p.355-364

2013

Volltextzugriff (PDF)

Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients

Bone marrow transplantation (Basingstoke), 2022-03, Vol.57 (3), p.423-430

2022

Volltextzugriff (PDF)

ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia

Leukemia, 2020-07, Vol.34 (7), p.1907-1923

2020

Volltextzugriff (PDF)

Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors

Molecular therapy, 2018-04, Vol.26 (4), p.1137-1153

2018

Volltextzugriff (PDF)

Autologous cell-based therapy for treatment of large bone defects: from bench to bedside

European journal of trauma and emergency surgery (Munich : 2007), 2018-10, Vol.44 (5), p.649-665

2018

Volltextzugriff (PDF)

Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates

Bone marrow transplantation (Basingstoke), 2014-03, Vol.49 (3), p.338-348

2014

Volltextzugriff (PDF)

Automated isolation of primary antigen-specific T cells from donor lymphocyte concentrates: results of a feasibility exercise

Vox sanguinis, 2015-11, Vol.109 (4), p.387-393

2015

Volltextzugriff (PDF)

A single dose of donor lymphocytes depleted of anti-host reactive T cells (ATIR101) following T-cell-depleted haploidentical HSCT is safe and efficaceous

CYTOTHERAPY, 2019-05, Vol.21 (5), p.S20-S21

2019

Volltextzugriff (PDF)

Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines

Blood, 2006-01, Vol.107 (1), p.79-86

2006

Volltextzugriff (PDF)

Efficacy and Safety of a Single Dose of Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Following T-Cell-Depleted Haploidentical HSCT: A Pooled Analysis of Two Phase II Studies

BLOOD, 2018-11, Vol.132 (Supplement 1), p.120-120

2018

Volltextzugriff (PDF)

1 – 25 von 176

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(174)

Publikationsform

Sprache

Englisch
(168)
Japanisch
(20)
Deutsch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Hematopoietic stem cell mobilization: updated conceptual renditions

Mesenchymal stromal cells for osteonecrosis

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

RBC depletion from a PBSC graft

Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes

Superior physical and mental health of healthy volunteers before and five years after mobilized stem cell donation

The osteo-inductive activity of bone-marrow-derived mononuclear cells resides within the CD14+ population and is independent of the CD34+ population

Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5·0, a novel, automatic interface-controlled apheresis system: results from the first feasibility trial

The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor

Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study

Effects of the small-molecule inhibitor of integrin α4, TBC3486, on pre-B-ALL cells

Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation

Feasibility of IL-15-activated cytokine-induced killer cell infusions after haploidentical stem cell transplantation

Delayed onset of graft‐versus‐host disease in immunodeficent human leucocyte antigen‐DQ8 transgenic, murine major histocompatibility complex class II‐deficient mice repopulated by human peripheral blood mononuclear cells

Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients

ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia

Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors

Autologous cell-based therapy for treatment of large bone defects: from bench to bedside

Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates

Automated isolation of primary antigen-specific T cells from donor lymphocyte concentrates: results of a feasibility exercise

A single dose of donor lymphocytes depleted of anti-host reactive T cells (ATIR101) following T-cell-depleted haploidentical HSCT is safe and efficaceous

Hierarchy of molecular-pathway usage in bone marrow homing and its shift by cytokines

Efficacy and Safety of a Single Dose of Donor Lymphocytes Depleted of Alloreactive T-Cells (ATIR101) Following T-Cell-Depleted Haploidentical HSCT: A Pooled Analysis of Two Phase II Studies

Mesenchymal stromal cells from pooled mononuclear cells of multiple bone marrow donors as rescue therapy in pediatric severe steroid-refractory graft-versus-host disease: a multicenter survey

Suchergebnisse filtern